Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Schildkraut, Joellen M ^a,b   Iversen, Edwin S ^a,b   Wilson, Melanie A ^a   Clyde, Merlise A ^a   Moorman, Patricia G ^a,b   Palmieri, Rachel T ^c   Whitaker, Regina ^a   Bentley, Rex C ^a   Marks, Jeffrey R ^a,b   Berchuck, Andrew ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACH1 GENE; BAYES THEOREM; CANCER INVASION; CHEK2 GENE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; LIG4 GENE; MAJOR CLINICAL STUDY; MARKER GENE; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; UNITED STATES; CASE CONTROL STUDY; CYSTADENOCARCINOMA; GENETICS; INFORMATION PROCESSING; OVARY TUMOR; PROBABILITY; RISK; STATISTICAL MODEL;

PROTEIN P53;

BAYES THEOREM; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; DATA COLLECTION; DNA DAMAGE; DNA REPAIR; FEMALE; HUMANS; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY; RISK; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956331205     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010061     Document Type: Article

References (38)

1. American Cancer Society (2009) Cancer facts & figures 2009. Atlanta, GA: American Cancer Society. v p.
2. Moorman PG, Calingaert B, Palmieri RT, Iversen ES, Bentley RC, et al. (2008) Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. American Journal of Epidemiology 167: 1059-1069.
3. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, et al. (2002) Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. American Journal of Epidemiology 155: 217-224.
4. Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, et al. (2004) Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. American Journal of Obstetrics and Gynecology 191: 733-740.
5. Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, et al. (2002) Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes and Control 13: 807-811.
6. Murdoch WJ, Townsend RS, McDonnel AC (2001) Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biology of Reproduction 65: 1417-1424.
7. Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, et al. (2007) Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Cancer Epidemiology, Biomarkers and Prevention 16: 473-480.
8. Ames BN, Gold LS (1990) Too many rodent carcinogens: mitgenesis increases mutagenesis. Science 249: 970-971.
9. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE (1990) Increased cell division as a cause of human cancer. Cancer Research 50: 7415-7421.
10. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiology, Biomarkers and Prevention 11: 1513-1530.
11. Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA (2008) DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8: 193-204.
12. Gowen LC, Avrutskaya AV, Latour AM, Koller BH, Leadon SA (1998) BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281: 1009-1012.
13. Moynahan ME, Chiu JW, Koller BH, Jasin M (1999) Brca1 controls homologydirected DNA repair. Molecular Cell 4: 511-518.
14. Berchuck A, Kohler MF, Hopkins MP, Humphrey PA, Robboy SJ, et al. (1994) Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. Gynecologic Oncology 52: 232-236.
15. Kmet LM, Cook LS, Magliocco AM (2003) A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer 97: 389-404.
16. Havrilesky L, Darcy M, Hamdan H, Priore RL, Leon J, et al. (2003) Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study. Journal of Clinical Oncology 21: 3814-3825.
17. Wilson MA, Iversen ES, Clyde MA, Schmidler SC, Schildkraut JM (2009) Bayesian Model Search and Multilevel Inference for SNP Association Studies. Annals of Applied Statistics. In press.
18. Stephens M, Balding DJ (2009) Bayesian statistical methods for genetic association studies. Nat Rev Genet 10: 681-690.
19. Hoeting JA, Madigan D, Raftery AE, Volinsky CT (2000) Bayesian model averaging: A tutorial (vol 14, pg 382, 1999). Statistical Science 15: 193-195.
20. Clyde M, George EI (2004) Model uncertainty. Statistical Science 19: 81-94.
21. Schildkraut JM, Moorman PG, Bland AE, Halabi S, Calingaert B, et al. (2008) Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup. Cancer Epidemiology, Biomarkers and Prevention 17: 585-593.
22. The International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789-796.
23. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. American Journal of Human Genetics 74: 106-120.
24. Emigh TH (1980) A comparison of tests for Hardy-Weinberg Equalibrium. Biometrics. pp 627-642.
25. Kass RE, Raftery AE (1995) Bayes factors. Journal of the American Statistical Association 90: 773-795.
26. Wakefield J (2007) A Bayesian measure of the probability of false discovery in genetic epidemiology studies. American Journal of Human Genetics 81: 208-227.
27. Goodman SN (1999) Toward evidence-based medical statistics. 2: The Bayes factor. Annals of Internal Medicine 130: 1005-1013.
28. Jeffreys H (1961) Theory of Probability; Oxford U, editor. Oxford, UK: Oxford University Press.
29. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
30. Xu Z, Taylor JA (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 37: W600-605.
31. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biology 2: e363.
32. Sunyaev S, Ramensky V, Koch I, Lathe W, 3rd, Kondrashov AS, et al. (2001) Prediction of deleterious human alleles. Human Molecular Genetics 10: 591-597.
33. Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, et al. (2009) Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Research 69: 2349-2357.
34. Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, et al. (2005) Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. International Journal of Cancer 117: 611-618.
35. Song H, Ramus SJ, Quaye L, DiCioccio RA, Tyrer J, et al. (2006) Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis 27: 2235-2242.
36. Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA, et al. (2007) Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. PLoS One 2: e268.
37. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, et al. (2009) Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer 100: 412-420.
38. Beesley J, Jordan SJ, Spurdle AB, Song H, Ramus SJ, et al. (2007) Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Cancer Epidemiology, Biomarkers and Prevention 16: 2557-2565.